Tue, May 16 2006 09:00 AM
Mission #26: Transfection of Carcinoma Cell Lines
amaxa's Nucleofector Technology - the best non-viral transfection system for difficult-to-transfect carcinoma cell lines
- Up to 81% transfection efficiency, e.g. for PC-3.
- Optimized protocols, including cell culture details.
- Up to 88% viability, e.g. for DU 145.
- Optimization for all cell lines within 2 weeks.
- More than 200 entries for cancer cells in our
cell database - More than 80 publications for cancer cells in our citation database.
